Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | CA4 | P22748 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 4/20 | 0.51 |
| ▸ | NPC1 | O15118 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10221538 | 0.85 | SMN1; SMN2 (0.74) | SMN1; SMN2MEN1CYP1A2KMT2ATP53 | |
| SCHEMBL11515168 | 0.85 | MEN1 (0.73) | SMN1; SMN2MEN1CYP1A2KMT2AALDH1A1 | |
| SCHEMBL7929897 | 0.85 | MEN1 (0.73) | SMN1; SMN2MEN1CYP1A2KMT2AALDH1A1 | |
| SCHEMBL11515413 | 0.83 | SMN1; SMN2 (0.69) | SMN1; SMN2MEN1CYP1A2KMT2ATP53 | |
| SCHEMBL6375789 | 0.81 | MEN1 (0.68) | SMN1; SMN2MEN1CYP1A2KMT2AALDH1A1 | |
| SCHEMBL11518015 | 0.81 | MEN1 (0.68) | SMN1; SMN2MEN1CYP1A2KMT2AALDH1A1 | |
| SCHEMBL9892978 | 0.80 | SMN1; SMN2 (0.67) | SMN1; SMN2MEN1CYP1A2KMT2AALDH1A1 | |
| SCHEMBL3807415 | 0.80 | SMN1; SMN2 (0.67) | SMN1; SMN2MEN1CYP1A2KMT2AALDH1A1 | |
| SCHEMBL28676132 | 0.79 | SMN1; SMN2 (0.65) | SMN1; SMN2MEN1CYP1A2KMT2AALDH1A1 | |
| SCHEMBL9891528 | 0.79 | KMT2A (0.65) | SMN1; SMN2MEN1CYP1A2KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8383615-B2 | Azetidine 2-carboxamide derivatives which modulate the CB2 receptor | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-02-26 | — | — | US | disclosed |
| US-20120142666-A1 | Azetidine 2-Carboxamide Derivatives Which Modulate The CB2 Receptor | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120142666-A1 | Azetidine 2-Carboxamide Derivatives Which Modulate The CB2 Receptor | CNR2, CNR1, OPRL1 | SMN1; SMN2 4282/4885MEN1 4667/4885CYP1A2 338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.